Advertisement

Blood donor screening for HIV infection: introduction in the United Kingdom and Europe and its impact on transfusion medicine

  • D. B. L. McClelland

Abstract

The preceding chapters have dealt with the nature of the immunological tests which are available to detect HIV infection, and describe the blood donor screening programmes operating in the United States. This chapter reflects the experience of the first year of routine HIV testing of blood donors in the United Kingdom and gives a view, necessarily very incomplete, of the situation in some other European countries.

Keywords

Blood Donor Donor Screening Transfusion Service Autologous Transfusion Blood Donor Screening 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alter, H. J. (1986) Transmission of LAV/HTLV-III by blood products, in International Conference on AIDS, Paris, June 1986 (Program and Abstracts), p. 6, Communication SP10.Google Scholar
  2. Barclay, G. R., Hopcroft, W. and McClelland, D. B. L. (1986) What is an ‘equivocal’ negative HTLV-III antibody test in blood donors? Lancet, i, 912–13.CrossRefGoogle Scholar
  3. Böttiger, M. et al. (1986) Presentation at International Conference on AIDS, Paris, June 1986, Poster 662.Google Scholar
  4. Brettle, R. P., Davidson, J., Davidson, S. J., Gray, J. M. N., Inglis, J. M., Conn, J. S., Bath, G. E., Gillon, J. and McClelland, D. B. L. (1986) HTLV-III antibodies in an Edinburgh clinic. Lancet, i, 1099.CrossRefGoogle Scholar
  5. Caiazza, S. S. (1985) Alternative test sites for screening blood for antibodies to AIDS virus. N. Engl. J. Med., 313, 1158.CrossRefGoogle Scholar
  6. Carlson, J. R. et al. (1985) Lancet, i, 1388.CrossRefGoogle Scholar
  7. CDC (1986a) Human T-lymphotropic virus type Ill/lymphadenopathy-associated virus antibody testing at alternate sites. MMWR, 35, 284–7.Google Scholar
  8. CDC (1986b) Transfusion associated human T-lymphotropic virus type III/lym-phadenopathy-associated virus infection from a seronegative donor — Colorado. MMWR, 35, 389–91.Google Scholar
  9. CDC (1986c) Human T-lymphotropic virus type Ill/lymphadenopathy-associated virus antibody prevalence in U.S. Military recruit applicants. MMWR, 35, 421–4.Google Scholar
  10. Contreras, M., Hewitt, P. E., Barbara, J. A. and Mochnaty, P. Z. (1985) Blood donors at high risk of transmitting the acquired immune deficiency syndrome. Brit. Med. J., 290, 749–50.CrossRefGoogle Scholar
  11. Couroucé, A. M., Smilovici, W., North, M. L. and the Study Group of the French Society of Blood Transfusion (1986) Blood donors positive for anti-LAV antibodies in France: prevalence according to different criteria, in International Conference on AIDS, Paris, June 1986 (Program and Abstracts), p. 100, Communication 45.Google Scholar
  12. Coutinho, R. A. (1986) The natural history of LAV/HTLV-III infection, in International Conference on AIDS, Paris, June 1986 (Program and Abstracts), p. 99, Communication 37.Google Scholar
  13. Esteban, J. I., Wai-Kuo Shih, J., Tai, C. C., Bodner, A. J., Kay, J. W. D. and Alter, H. J. (1985) Importance of Western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet, ii, 1083–6.CrossRefGoogle Scholar
  14. Giachino, O. et al. (1986) Presentation at International Conference on AIDS, June 1986, Poster 389.Google Scholar
  15. Holland, P. V. et al. (1985) Transfusion, 25, 395–7PubMedCrossRefGoogle Scholar
  16. Huisman, H. G., Winkel, I., Lelie, N., Tersmette, M., Goudsmit, J. and De Lange, J. (1986a) Comparison of three different immunoassays in their ability to establish in human sera the onset of IgG antibody response to LAV/HTLV-III infection, in International Conference on AIDS, Paris, June 1986 (Program and Abstracts), p. 145, Poster 635.Google Scholar
  17. Huisman, H. G., Winkel, I., Lelie, N., Tersmette, M., Goudsmit, J. and Miedema, F. (1986b) A LAV/HTLV-III radioimmuno-assay for confirmatory testing, in International Conference on AIDS, Paris, June 1986 (Program and Abstracts), p. 148, Poster 653.Google Scholar
  18. Jochen, A. B. B. et al. (1986) Presentation on International Conference on AIDS, June 1986, Poster 391.Google Scholar
  19. Kruskall, M. S. (1986) New trends in transfusion medicine: autologous transfusions and directed donations, in NIH Consensus Development Conference. Impact of Routine HTLV-III Antibody Testing of Blood and Plasma Donors on Public Health, Bethesda, July 1986 (Program and Abstracts), pp. 83–7.Google Scholar
  20. Kuhnl et al. (1986), Vox Sang, 51 (Suppl. 1), 15–20.PubMedCrossRefGoogle Scholar
  21. Lange, J. M. A., Coutinho, R. A., Krone, W. J. A., Verdonck, L. F., Danner, S. A., Van der Noordaa, J. and Goudsmit, J. (1986) Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Brit. Med. J., 292, 228–30.CrossRefGoogle Scholar
  22. Ludlam, C. A., Steel, C. M., Cheinsong-Popov, R., McClelland, D. B. L., Tucker, J., Tedder, R. S., Weiss, R. A., Philp, I. and Prescott, R. J. (1985) Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet, ii, 233–6.CrossRefGoogle Scholar
  23. Mercadier, A., Jullien, A. M., Guiard, J., Andreu, G., Noel, L., Couroucé, A. M. and the AIDS Study Group of the French National Blood Transfusion Society (1986) LAV/HTLV-III seropositivity among recipients of blood and blood components in Paris area, in International Conference on AIDS, Paris, June 1986 (Program and Abstracts), p. 102, Communication 58.Google Scholar
  24. Mortimer, P. T., Parry, J. V., Mortimer, J. Y. (1986) Which anti HTLV-III/LAV assays for screening and confirmatory testing? Lancet, ii, 873–7.Google Scholar
  25. NIH Consensus Development Conference (1986) Draft Consensus Statement: Impact of Routine HTLV-III Antibody Testing of Blood and Plasma Donors on Public Health, Bethesda, July 1986.Google Scholar
  26. O’Shaughnessy, M. V. et al. (1986) International Conference on AIDS, Abstract 417.Google Scholar
  27. Payne, B. C., Bishop, P., Rasheed, S., Gill, P., Levine, A. and Parker, J. W. (1986) The detection of HTLV-III/LAV associated surface antigens in human blood lymphocytes by flow cytometry, in International Conference on AIDS, Paris, June 1986 (Program and Abstracts) p. 144, Poster 633.Google Scholar
  28. Peutherer, J. F., Edmond, E., Simmonds, P., Dickson, J. D. and Bath, G. E. (1985) HTLV-III antibody in Edinburgh drug addicts. Lancet, ii, 1129–30.CrossRefGoogle Scholar
  29. Reesink, H. W. et al. (1986) International Conference on AIDS, Abstract 426.Google Scholar
  30. Rubin, C. P. et al. (1986) International Conference on AIDS, Abstract 420.Google Scholar
  31. Simmonds, P., Peutherer, J. F. and McClelland, D. B. L. (1986) HTLV-III/LAV antibody testing: confirmation methodologies and future prospects, in The Safety of Blood and Blood Products in Relation to AIDS. Proceedings of WHO Meeting, Geneva (ed. J. Petricciani), April 1986, to be published 1986.Google Scholar
  32. Ulstrup, J. C., Skaug, K., Figenschau, K. J., Ørstavik, I., Bruun, J. N. and Petersen, G. (1986) Sensitivity of Western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Lancet, i, 1151–2.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1987

Authors and Affiliations

  • D. B. L. McClelland

There are no affiliations available

Personalised recommendations